Clinical Site Agreement Template for the United States

A Clinical Site Agreement is a comprehensive contract that governs the relationship between research sponsors and clinical sites conducting medical research trials in the United States. This essential document establishes clear roles, responsibilities, and obligations for all parties involved in clinical research, ensuring compliance with federal regulations and protecting the rights of research participants.

When do you need this document?

You need a Clinical Site Agreement whenever you're planning to conduct clinical research involving human subjects at a healthcare facility or research institution. This includes pharmaceutical companies sponsoring drug trials, medical device manufacturers testing new products, academic institutions conducting investigator-initiated studies, and contract research organizations managing multi-site trials. The agreement is required before any research activities begin and must be executed prior to subject enrollment, protocol implementation, or any study-related procedures.

Key legal considerations

Your Clinical Site Agreement must address several critical legal elements to ensure comprehensive protection and compliance. The scope of services section should clearly define study procedures, subject enrollment targets, data collection requirements, and timeline expectations. Compliance provisions must outline adherence to Good Clinical Practice guidelines, FDA regulations, and institutional policies. Financial terms should specify payment schedules, budget allocations, and cost responsibilities for study-related activities. Intellectual property clauses need to address data ownership, publication rights, and confidentiality obligations. Indemnification provisions should protect parties from liability arising from protocol violations, adverse events, or regulatory non-compliance. The agreement must also include termination clauses allowing either party to end the relationship under specified circumstances while protecting ongoing subject safety and data integrity.

Legal requirements in United States

United States clinical research is governed by extensive federal regulations that your Clinical Site Agreement must address comprehensively. Under 21 CFR Part 50, you must ensure proper informed consent procedures and participant protections are clearly defined. The agreement must comply with 21 CFR Part 56 requirements for Institutional Review Board oversight, including IRB approval processes and ongoing review obligations. For investigational drugs, 21 CFR Part 312 mandates specific sponsor responsibilities, safety reporting requirements, and protocol compliance measures. Medical device studies must adhere to 21 CFR Part 812 Investigational Device Exemption regulations. HIPAA compliance is mandatory for any research involving protected health information, requiring specific privacy safeguards and data handling procedures. Your agreement should also address state-specific requirements, institutional policies, and Good Clinical Practice standards to ensure complete regulatory compliance throughout the study duration.